Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature
Sen Hee Tay, Michelle Min Xuan Toh, Yee Liang Thian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
Deep Shah, Brian W. Soper, Lindsay S. Shopland
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature
Lisa L. Liu, Marcus Skribek, Ulrika Harmenberg, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e005841-e005841
Open Access | Times Cited: 39
Cytokine-mediated CAR T therapy resistance in AML
Anand S. Bhagwat, Leonel Torres, Olga Shestova, et al.
Nature Medicine (2024)
Closed Access | Times Cited: 9
Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?
Tamiko R. Katsumoto, Kalin L Wilson, Vinay K. Giri, et al.
Immunotherapy Advances (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 30
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge
Federica Frascaro, Nicola Bianchi, Federico Sanguettoli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7737-7737
Open Access | Times Cited: 17
Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review
Francis Ntwali, Quentin Gilliaux, Patrick M. Honorè
American Journal of Case Reports (2024) Vol. 25
Open Access | Times Cited: 6
Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution
Kerstin Thol, Piotr Pawlik, Nicholas McGranahan
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers
Yanni Wang, Jianling Zou, Yun Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Role of IL-6/STAT3 Axis in Resistance to Cisplatin in Gastric Cancers
Simona Laurino, Mariarita Brancaccio, Tiziana Angrisano, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 694-694
Open Access | Times Cited: 13
Humanized Mouse Models for Immuno‐oncology Drug Discovery
Rajendra Kumari, Gerold Feuer, Ludovic Bourré
Current Protocols (2023) Vol. 3, Iss. 8
Open Access | Times Cited: 13
Unlocking the adenosine receptor mechanism of the tumour immune microenvironment
Yecheng Han, Chenshuang Dong, Mingwang Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study
Toshiyuki Sumi, Yutaro Nagano, Keiki Yokoo, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Immune checkpoint inhibitor-associated myocarditis: a review of current state of knowledge
Keila C. Ostos-Mendoza, Valeria Saraiba-Rabanales, Paola Gutierrez-Gallegos, et al.
The Journal of Cardiovascular Aging (2025) Vol. 5, Iss. 1
Open Access
Pathogenesis, Diagnosis, and Management of Cytokine Release Syndrome in Patients with Cancer: Focus on Infectious Disease Considerations
Panos Arvanitis, Andreas Tziotis, Spyridon Papadimatos, et al.
Current Oncology (2025) Vol. 32, Iss. 4, pp. 198-198
Open Access
The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: A systematic review and meta-analysis
F. Albano, Francesco Severini, Giovanni Calice, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167821-167821
Open Access
Bridging the Gap: Tailoring an Approach to Treatment in Febrile Infection‐Related Epilepsy Syndrome
Yihui Goh, Sen Hee Tay, Leonard L.L. Yeo, et al.
Neurology (2023) Vol. 100, Iss. 24, pp. 1151-1155
Open Access | Times Cited: 12
Imaging assessment of toxicity related to immune checkpoint inhibitors
Antonia M. Berz, Sarah Boughdad, Naïk Vietti Violi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Severe cytokine release syndrome induced by immune checkpoint inhibitors in cancer patients – A case report and review of the literature
Y Zhang, Xiaoyue Wen, Yaqi Ouyang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24380-e24380
Open Access | Times Cited: 4
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy
Noha Abdel‐Wahab, María E. Suarez‐Almazor
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 873-893
Closed Access | Times Cited: 4
Management of Toxicities Associated with BCMA, GPRC5D, and FcRH5-Targeting Bispecific Antibodies in Multiple Myeloma
Darren Pan, Joshua Richter
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 6, pp. 237-245
Closed Access | Times Cited: 4
A mechanistic, functional, and clinical perspective on targeting CD70 in cancer
Sandeep Kumar, Sowdhamini Mahendiran, Rakesh Sathish Nair, et al.
Cancer Letters (2024) Vol. 611, pp. 217428-217428
Open Access | Times Cited: 4
Fatal Outcome of Pembrolizumab-Related Cytokine Release Syndrome in a Patient With Concurrent Parainfluenza Infection
Wei-Hung Hung, Yu-Sheng Hu, Lining Fang, et al.
Annals of Internal Medicine Clinical Cases (2025) Vol. 4, Iss. 2
Closed Access
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
Tomoyuki Otsuka, Yoshiki Kojitani, Fumio Imamura, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Role of Soluble Cytokine Receptors in Gastric Cancer Development and Chemoresistance
Francesco Severini, Geppino Falco, Tiziana Notarangelo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2534-2534
Open Access
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4335-4357
Open Access
Page 1 - Next Page

Scroll to top